{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:28:35Z","timestamp":1777350515223,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,2,28]],"date-time":"2006-02-28T00:00:00Z","timestamp":1141084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s00280-006-0208-7","type":"journal-article","created":{"date-parts":[[2006,2,27]],"date-time":"2006-02-27T11:42:06Z","timestamp":1141040526000},"page":"607-617","source":"Crossref","is-referenced-by-count":24,"title":["Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging"],"prefix":"10.1007","volume":"58","author":[{"given":"Ruediger E.","family":"Port","sequence":"first","affiliation":[]},{"given":"Christian","family":"Schuster","sequence":"additional","affiliation":[]},{"given":"Christa R.","family":"Port","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Bachert","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,2,28]]},"reference":[{"key":"208_CR1","unstructured":"Beal SL, Sheiner LB (eds) (1999) NONMEM version V.1.1, User\u2019s guides. NONMEM Project Group, University of California San Francisco, San Francisco"},{"key":"208_CR2","unstructured":"Blumbergs P (1992). U. S. Pat. No. 5,110,919. URL: http:\/\/www.patft.uspto.gov\/netahtml\/srchnum.htm"},{"key":"208_CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00685904","volume":"33","author":"A Bonetti","year":"1994","unstructured":"Bonetti A, Chatelut E, Kim S (1994) An extended-release formulation of methotrexate for subcutaneous administration. Cancer Chemother Pharmacol 33:303\u2013306","journal-title":"Cancer Chemother Pharmacol"},{"key":"208_CR4","first-page":"42","volume":"25","author":"EA Brownson","year":"1998","unstructured":"Brownson EA, Langston M, Tsai AG, Gillespie T, Davis TP, Intaglietta M, Sankaram MB (1998) Biodistribution during sustained release from DepoFoam(\u2122, a lipid-based parenteral drug delivery system. Proc Int Symp Control Rel Bioact Mater 25:42\u201343","journal-title":"Proc Int Symp Control Rel Bioact Mater"},{"key":"208_CR5","first-page":"261","volume":"50","author":"MC Chamberlain","year":"1993","unstructured":"Chamberlain MC, Khatibi S, Kim JC, Howell SB, Chatelut E, Kim S (1993) Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101). A phase I study. Acta Neurol 50:261\u2013264","journal-title":"Acta Neurol"},{"key":"208_CR6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mrm.20395","volume":"53","author":"HA Chen","year":"2005","unstructured":"Chen HA, Le Visage C, Qiu B, Du X, Ouwerkerk R, Leong KW, Yang X (2005) MR imaging of biodegradable polymeric microparticles: a potential method of monitoring local drug delivery. Magn Reson Med 53:614\u2013620","journal-title":"Magn Reson Med"},{"key":"208_CR7","first-page":"39","volume-title":"Liposomes. From biophysics to therapeutics","author":"PR Cullis","year":"1987","unstructured":"Cullis PR, Hope MJ, Bally MB, Madden TD, Mayer LD, Janoff AS (1987) Liposomes as pharmaceuticals. In: Ostro MJ (eds) Liposomes. From biophysics to therapeutics. Marcel Dekker, New York, pp 39\u201372"},{"key":"208_CR8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1357-4310(95)80091-3","volume":"1","author":"AJ Domb","year":"1995","unstructured":"Domb AJ (1995) Polymeric carriers for regional drug therapy. Mol Med Today 1:134\u2013139","journal-title":"Mol Med Today"},{"key":"208_CR9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jmri.1880070114","volume":"7","author":"KM Donahue","year":"1997","unstructured":"Donahue KM, Weisskoff RM, Burstein D (1997) Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imag 7:102\u2013110","journal-title":"J Magn Reson Imag"},{"issue":"6","key":"208_CR10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-2008-1052730","volume":"142","author":"R Felix","year":"1985","unstructured":"Felix R, Semmler W, Sch\u00f6rmer W, Laniado M (1985) Kontrastmittel in der magnetischen Resonanztomographie. Fortschr R\u00f6ntgenstr 142(6):641\u2013646","journal-title":"Fortschr R\u00f6ntgenstr"},{"key":"208_CR11","first-page":"585","volume":"47","author":"G Firth","year":"1984","unstructured":"Firth G, Oliver AS, McKeran RO (1984) Studies on the intracerebral injection of bleomycin free and entrapped within liposomes in the rat. J Neurol 47:585\u2013589","journal-title":"J Neurol"},{"issue":"6","key":"208_CR12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-200241060-00002","volume":"41","author":"AP Fleming","year":"2002","unstructured":"Fleming AP, Saltzman WM (2002) Pharmacokinetics of the carmustine implant. Clin Pharmacokinet 41(6):403\u2013419","journal-title":"Clin Pharmacokinet"},{"key":"208_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003088-200241020-00002","volume":"41","author":"V Gandhi","year":"2002","unstructured":"Gandhi V, Plunkett W (2002) Cellular and clinical pharmacology of fludarabine. Clin Pharmacokin 41:93\u2013103","journal-title":"Clin Pharmacokin"},{"key":"208_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/B:DRUG.0000006172.65135.3e","volume":"22","author":"C Guerin","year":"2004","unstructured":"Guerin C, Olivi A, Weingart JD, Lawson HC, Brem H (2004) Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Inv New Drugs 22:27\u201337","journal-title":"Inv New Drugs"},{"key":"208_CR15","first-page":"243","volume":"7","author":"KJ Harrington","year":"2001","unstructured":"Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters M, Vile RG, Stewart JSW (2001) Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 7:243\u2013254","journal-title":"Clin Cancer Res"},{"issue":"5","key":"208_CR16","first-page":"447","volume":"71","author":"S Kim","year":"1987","unstructured":"Kim S, Howell SB (1987) Multivesicular liposomes containing cytarabine for slow-release sc administration. Cancer Treat Rep 71(5):447\u2013450","journal-title":"Cancer Treat Rep"},{"key":"208_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00686214","volume":"33","author":"T Kim","year":"1993","unstructured":"Kim T, Kim J, Kim S (1993) Extended release formulation of morphine for subcutaneous administration. Cancer Chemother Pharmacol 33:187\u2013190","journal-title":"Cancer Chemother Pharmacol"},{"key":"208_CR18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0163-7827(02)00004-8","volume":"41","author":"S Mantripragada","year":"2002","unstructured":"Mantripragada S (2002) A lipid based depot (DepotFoam technology) for sustained release drug delivery. Prog Lipid Res 41:392\u2013406","journal-title":"Prog Lipid Res"},{"issue":"15","key":"208_CR19","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1158\/0008-5472.CAN-05-0161","volume":"56","author":"Y Mardor","year":"2005","unstructured":"Mardor Y, Rahav O, Zauberman Y, Lidar Z, Ocherashvilli A, Daniels D, Yiftach R, Maier RSE, Orenstein A, Ram Z (2005) Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res 56(15):6858\u20136863","journal-title":"Cancer Res"},{"key":"208_CR20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0005-2736(85)90084-7","volume":"817","author":"LD Mayer","year":"1985","unstructured":"Mayer LD, Hope MJ, Cullis PR, Janoff AS (1985) Solute distributions and trapping efficencies observed in freeze-thawed multilamellar vesicles. Biochim Biophys Acta 817:193\u2013196","journal-title":"Biochim Biophys Acta"},{"key":"208_CR21","first-page":"51","volume":"88","author":"P Menei","year":"2003","unstructured":"Menei P, Benoit JP (2003) Implantable drug-releasing biodegradable microspheres for local treatment of brain glioma. Acta Neurochir Suppl 88:51\u201355","journal-title":"Acta Neurochir Suppl"},{"key":"208_CR22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/mrm.1910300415","volume":"30","author":"G Navon","year":"1993","unstructured":"Navon G (1993) Complete elimination of the extracellular 23Na NMR signal in triple quantum filtered spectra of rat hearts in the presence of shift reagents. Magn Reson Med 30:503\u2013506","journal-title":"Magn Reson Med"},{"key":"208_CR23","first-page":"229","volume-title":"Drug delivery systems in cancer therapy","author":"EK Orenberg","year":"2004","unstructured":"Orenberg EK (2004) Intralesional chemotherapy with injectable collagen gel formulations. In: Brown DM (eds) Drug delivery systems in cancer therapy. Humana Press, Totowa, pp 229\u2013246"},{"key":"208_CR24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.cgt.7700520","volume":"10","author":"WB Parker","year":"2003","unstructured":"Parker WB, Allan PW, Hassan AE, Secrist JA III, Sorscher EJ, Waud WR (2003) Antitumor activity of 2-fluoro-2\u2032-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase. Cancer Gene Ther 10:23\u201329","journal-title":"Cancer Gene Ther"},{"key":"208_CR25","unstructured":"Port R (2003) SOP 14: population pharmacokinetic analysis. In: Gastl G, Berdel W, Edler L, Jaehde U, Port R, Mross K, Scheulen M, Sindermann H, Dittrich C (eds) Standard operating procedures for clinical trials of the CESAR Central European Society for Anticancer Drug Research\u2014EWIV. Onkologie 26(Suppl 6):60\u201366. URL: http:\/\/www.content.karger.com\/ProdukteDB\/produkte.asp?doi=000075017"},{"key":"208_CR26","unstructured":"Port RE (1996) Estimating individual pretreatment levels of a pharmacologic response variable. Population Approach Group in Europe, Sandwich UK, June 14\u201315. URL: http:\/\/www.page-meeting.org\/"},{"key":"208_CR27","unstructured":"Port RE (2003) Populations-Pharmakokinetik und individuelle Dosisanpassung. In: Zeller WJ, zur Hausen H (eds) Onkologie\u2014Grundlagen, Diagnostik, Therapie, Entwicklungen (16. Erg\u00e4nzungslieferung). ecomed-Verlag, Landsberg, pp IV-8.1, 1\u201313 URL: http:\/\/www.dkfz-heidelberg.de\/pharmakologie\/04\\_IV-8.1\\_Port.pdf"},{"key":"208_CR28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2125.1998.00797.x","volume":"46","author":"RE Port","year":"1998","unstructured":"Port RE, Ding RW, Fies T, Schaerer K (1998) Predicting the time course of haemoglobin in children treated with erythropoietin for renal anaemia. Br J Clin Pharmacol 46:461\u2013466","journal-title":"Br J Clin Pharmacol"},{"key":"208_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002800050946","volume":"44","author":"RE Port","year":"1999","unstructured":"Port RE, Hanisch F, Becker M, Bachert P, Zeller J (1999) Local disposition kinetics of floxuridine after intratumoral and subcutaneous injection as monitored by 19F-nuclear magnetic resonance spectroscopy in vivo. Cancer Chemother Pharmacol 44:65\u201373","journal-title":"Cancer Chemother Pharmacol"},{"key":"208_CR30","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/mrm.1137","volume":"45","author":"RE Port","year":"2001","unstructured":"Port RE, Knopp MV, Brix G (2001) Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors. Magn Reson Med 45:1030\u20131038","journal-title":"Magn Reson Med"},{"key":"208_CR31","unstructured":"R Development Core Team (2004) R: a language and environment for statistical computing. R Foundation for Statistical Computing. ISBN 3-900051-00-3. URL: http:\/\/www.R-project.org"},{"key":"208_CR32","unstructured":"Rasband W, National Institute of Mental Health, Bethesda (2004). ImageJ. Image processing and analysis in java. URL: http:\/\/www.rsb.info.nih.gov\/ij\/"},{"key":"208_CR33","unstructured":"Rowland IJ, Maxwell RJ, Baluch S, Ojugo ASE, Griffiths JR, Leach MO (1993) Differential distribution of 5-fluorouracil and \u03b1-fluoro-\u03b2-alanine in both rat liver and tumour. In: Proceedings of the society of magnetic resonance in medicine (SMRM), vol 1, New York, pp 244"},{"key":"208_CR34","volume-title":"Clinical pharmacokinetics: concepts and applications","author":"M Rowland","year":"1995","unstructured":"Rowland M, Tozer TN (1995) Clinical pharmacokinetics: concepts and applications, 3rd edn. Williams & Wilkins, Baltimore","edition":"3"},{"key":"208_CR35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00689697","volume":"28","author":"R Roy","year":"1991","unstructured":"Roy R, Kim S (1991) Multivesicular liposomes containing bleomycin for subcutaneous administration. Cancer Chemother Pharmacol 28:105\u2013108","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Suppl 2","key":"208_CR36","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/S1076-6332(03)80283-0","volume":"9","author":"E Rubesova","year":"2002","unstructured":"Rubesova E, Berger F, Wendland MF, Hong K, Stevens KJ, Gooding CA, Lang P (2002) Gd-labeled liposomes for monitoring liposome-encapsulated chemotherapy. Acad Radiol 9(Suppl 2):S525\u2013S527","journal-title":"Acad Radiol"},{"key":"208_CR37","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1158\/0008-5472.CAN-03-3631","volume":"64","author":"R Saito","year":"2004","unstructured":"Saito R, Bringas JR, McKnight TR, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS (2004) Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res 64:2572\u20132579","journal-title":"Cancer Res"},{"key":"208_CR38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF01059333","volume":"13","author":"LB Sheiner","year":"1985","unstructured":"Sheiner LB (1985) Analysis of pharmacokinetic data using parametric models. II. Point estimates of an individual\u2019s parameters. J Pharmacokin Biopharm 13:515\u2013540","journal-title":"J Pharmacokin Biopharm"},{"key":"208_CR39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.pa.32.040192.001153","volume":"32","author":"LB Sheiner","year":"1992","unstructured":"Sheiner LB, Ludden TM (1992) Population pharmacokinetics\/dynamics. Annu Rev Pharmacol Toxicol 32:185\u2013209","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"208_CR40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF01061728","volume":"5","author":"LB Sheiner","year":"1977","unstructured":"Sheiner LB, Rosenberg B, Marathe VV (1977) Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokin Biopharm 5:445\u2013479","journal-title":"J Pharmacokin Biopharm"},{"key":"208_CR41","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/mrm.20074","volume":"51","author":"BL Viglianti","year":"2004","unstructured":"Viglianti BL, Abraham SA, Michelich CR, Yarmolenko PS, MacFall JR, Bally MB, Dewhirst MW (2004) In vivo monitoring of tissue pharmacokinetics of liposome\/drug using MRI: illustration of targeted delivery. Magn Reson Med 51:1153\u20131162","journal-title":"Magn Reson Med"},{"key":"208_CR42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ana.10688","volume":"54","author":"J Voges","year":"2002","unstructured":"Voges J, Reszka R, Gossmann A, Dittmar C, Richter R, Garlip G, Kracht L, Coenen HH, Sturm V, Wienhard K, Heiss WD, Jacobs AH (2002) Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann Neurol 54:479\u2013487","journal-title":"Ann Neurol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0208-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-006-0208-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0208-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:06:20Z","timestamp":1559037980000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-006-0208-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,28]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["208"],"URL":"https:\/\/doi.org\/10.1007\/s00280-006-0208-7","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,28]]}}}